KYNU and ovarian serous cystadenocarcinoma: KYNU is overexpressed in a variety of tumors, including cervical squamous cell carcinoma and endocervical adenocarcinoma, lymphoid neoplasm diffuse large B-cell lymphoma, esophageal carcinoma, head and neck squamous cell carcinoma, ovarian serous cystadenocarcinoma, pancreatic adenocarcinoma, skin cutaneous melanoma metastasis and stomach adenocarcinoma when compared to control peritumoral tissues (Figure 2A,B).